According to a prominent sell-side analyst who follows MNTA, every sell-side analyst on Wall Street understands that Teva’s Lovenox is DoA...
Two questions if I may: 1) when did they/this person come to that conclusion, and 2) what percentage of sell-side analysts believed differently before whatever the catalyst/date in question #1?